TNXP Buybacks
5 quarter-specific issuer repurchase-cash observations normalized from SEC filings, newest first. A filed zero remains visible; a missing filing fact is never converted into zero. This page shows rows 1–5; provenance stays internal.
| Issuer profile | Period end | Type | Reported cash |
|---|---|---|---|
| Tonix Pharmaceuticals Holding Corp. | 2025-12-31 | Reported repurchase cash | $7.81M |
| Tonix Pharmaceuticals Holding Corp. | 2025-06-30 | Reported repurchase cash | $2.9M |
| Tonix Pharmaceuticals Holding Corp. | 2025-03-31 | Reported repurchase cash | $3.05M |
| Tonix Pharmaceuticals Holding Corp. | 2023-12-31 | Reported repurchase cash | $0.00 |
| Tonix Pharmaceuticals Holding Corp. | 2023-03-31 | Reported repurchase cash | $13.97M |